POCS in Liver Transplantation Patients
Completed
Conditions studied: Liver Transplant; Complications
In brief
A prospective, multi-center, non-randomized, observational, consecutive case series, which will compare Endoscopic Retrograde Cholangiopancreatoscopy (ERCP) and cholangioscopy with Spy Glass Digital System (DS) procedure at 5-10 centers.
Key facts
- Study ID
- NCT03205072
- Run by
- Boston Scientific Corporation
- People needed
- 42
- Starts
- 2018-01-25
- Expected to finish
- 2022-03-24
- Last updated by the study team
- 2022-07-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Liver transplantation at least 1 month prior to POCS procedure
- Abnormal Liver Function Tests (LFTs) and/or biliary obstructive symptoms
- Prior cross sectional imaging (MRI and/or US and/or CT)
- Suspicion of anastomotic biliary stricture(s)
- Diameter of bile ducts deemed sufficient to accommodate cholangioscopy system based on baseline imaging
- Willing and able to provide a written informed consent to participate in the study
- Willing and able to comply with study procedures and follow-up schedule
You may not qualify if…
- Contraindication for an ERCP per local standard of practice
- Deemed contraindicated for POCS per local standard of practice
- Prior biliary treatment of biliary anastomotic stricture
- < 18 years old
- Documented life expectancy of less than 12 months.
Where it is running
- New York Presbyterian Hospital CUMC — New York, New York, United States
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
- Hospital das Clinicas — São Paulo, Brazil
- Erasmus Medical Center — Rotterdam, Netherlands
- Hospital Clinic de Barcelona — Barcelona, Spain
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.